Boston Scientific Corp (BSX)

Surgical & Medical Instruments & Apparatus

Latest Price

$43.65

TTM P/E

17.67

Normalized P/E

33.02

Div Yield

Book Value

16.77

P/B Ratio

2.60

Valuation metrics

EPS: $1.94

Book value / share: $17.37

Formula: √(22.5 × EPS × BVPS)

Graham Number

$27.54

37% downside

Norm. op. income: $1.6B (median of 7yr)

Tax rate: 19%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$2.77

94% downside

Base FCF: $1.8B (median of recent 5yr)

Growth: 21%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$62.84

+44% upside

EPS: $1.94

Target P/E: 33×

Formula: EPS × P/E

P/E Fair Value

$64.02

+47% upside

90.9% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	129.68M	$5.53B	8.82%	-2.14M	2026-06-30
Vanguard Capital Management LLC	97.09M	$4.14B	6.60%	+676.0K	2026-06-30
State Street Corp	70.11M	$2.99B	4.77%	+2.12M	2026-06-30
Primecap Management Co	50.52M	$2.16B	3.44%	+17.99M	2026-06-30
FMR LLC	45.70M	$1.95B	3.11%	-28.52M	2026-06-30
Jane Street Group, LLC	33.76M	$1.44B	2.30%	+27.26M	2026-06-30
Geode Capital Management, LLC	33.44M	$1.42B	2.27%	+154.3K	2026-06-30
Vanguard Portfolio Management LLC	29.79M	$1.27B	2.03%	-3.4K	2026-06-30
D. E. Shaw & Co., Inc.	27.27M	$1.16B	1.85%	+2.83M	2026-06-30
Massachusetts Financial Services Co	24.86M	$1.50B	1.69%	+13.86M	2026-06-30